Two different miRNAs overexpressed in ovarian cancer that specifically target PTEN have been identified [32,33], and immunohistochemistry has revealed that PTEN protein is absent in roughly 33% of STICs [34]. This evidence concerns the gene PTEN and ovarian carcinoma.